These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12619776)

  • 21. An update for epilepsy research and antiepileptic drug development: Toward precise circuit therapy.
    Wang Y; Chen Z
    Pharmacol Ther; 2019 Sep; 201():77-93. PubMed ID: 31128154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational approaches for innovative antiepileptic drug discovery.
    Talevi A
    Expert Opin Drug Discov; 2016 Oct; 11(10):1001-16. PubMed ID: 27454246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epilepsy biomarkers.
    Engel J; Pitkänen A; Loeb JA; Dudek FE; Bertram EH; Cole AJ; Moshé SL; Wiebe S; Jensen FE; Mody I; Nehlig A; Vezzani A
    Epilepsia; 2013 Aug; 54 Suppl 4(0 4):61-9. PubMed ID: 23909854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of GABAergic systems in the mechanism of action of antiepileptic drugs.
    Lloyd KG
    Therapie; 1983; 38(4):355-62. PubMed ID: 6359564
    [No Abstract]   [Full Text] [Related]  

  • 25. Systems biology, complexity, and the impact on antiepileptic drug discovery.
    Margineanu DG
    Epilepsy Behav; 2014 Sep; 38():131-42. PubMed ID: 24090772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epilepsy treatment: a paradigm shift is urgently need.
    Bartmann AP; Sander JW
    Arq Neuropsiquiatr; 2013 Mar; 71(3):180-2. PubMed ID: 23563719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiepileptics from gamma-aminobutyric acid.
    Satzinger G
    Arzneimittelforschung; 1994 Mar; 44(3):261-6. PubMed ID: 8192689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selected Molecular Targets for Antiepileptogenesis.
    Pawlik MJ; Miziak B; Walczak A; Konarzewska A; Chrościńska-Krawczyk M; Albrecht J; Czuczwar SJ
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiepileptogenic agents: how close are we?
    Temkin NR; Jarell AD; Anderson GD
    Drugs; 2001; 61(8):1045-55. PubMed ID: 11465868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Newer antiepileptic drugs].
    Matsuura M
    No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of action of antiepileptic drugs: the search for synergy.
    Stafstrom CE
    Curr Opin Neurol; 2010 Apr; 23(2):157-63. PubMed ID: 20125013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of meclofenamic acid on limbic epileptogenesis in mice kindling models.
    Jin M; Dai Y; Xu C; Wang Y; Wang S; Chen Z
    Neurosci Lett; 2013 May; 543():110-4. PubMed ID: 23567745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies.
    Löscher W
    Epilepsy Res; 2016 Oct; 126():157-84. PubMed ID: 27505294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis?
    Vezzani A
    Expert Opin Drug Saf; 2015 Apr; 14(4):583-92. PubMed ID: 25645535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The new generation of GABA enhancers. Potential in the treatment of epilepsy.
    Czuczwar SJ; Patsalos PN
    CNS Drugs; 2001; 15(5):339-50. PubMed ID: 11475940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GABA and epileptogenesis.
    Olsen RW; Avoli M
    Epilepsia; 1997 Apr; 38(4):399-407. PubMed ID: 9118844
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification and preclinical testing of novel antiepileptic compounds.
    Meldrum BS
    Epilepsia; 1997; 38 Suppl 9():S7-15. PubMed ID: 9578540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New antiepileptic drugs: from serendipity to rational discovery.
    Porter RJ; Rogawski MA
    Epilepsia; 1992; 33 Suppl 1():S1-6. PubMed ID: 1379532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments.
    Löscher W; Puskarjov M; Kaila K
    Neuropharmacology; 2013 Jun; 69():62-74. PubMed ID: 22705273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the medical treatment of epilepsy.
    Bazil CW; Pedley TA
    Annu Rev Med; 1998; 49():135-62. PubMed ID: 9509255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.